Averil Ma
- Immunology top 0.05%
- Immune Cell Function and Interaction 36
- T-cell and B-cell Immunology 34
- Immune Response and Inflammation 32
- interferon and immune responses 23
- Immunotherapy and Immune Responses 14
- Cancer Research top 0.2%
- NF-κB Signaling Pathways 49
- Oncology top 0.5%
- Molecular Biology top 0.5%
- Ubiquitin and proteasome pathways 11
- Hematology top 1%
-
- Clostridium difficile and Clostridium perfringens research 10
- Co-authors
- Barbara A. MalynnSophia ChaiDavid L. BooneMarcia ChienJames P. LodolcePatrick R. BurkettRima KokaFrederick W. Alt
- Cited by
- ImmunologyCancer ResearchOncology
- Partner nations
- United StatesJapanChina
In The Last Decade
Averil Ma
138 papers receiving 17.8k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Immunology 11.9k
- Cancer Research 4.3k
- Oncology 2.9k
- Molecular Biology 6.4k
- Hematology 744
Countries citing papers authored by Averil Ma
This map shows the geographic impact of Averil Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Averil Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Averil Ma more than expected).
Fields of papers citing papers by Averil Ma
This network shows the impact of papers produced by Averil Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Averil Ma. The network helps show where Averil Ma may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Averil Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 8 | |
| 4 | 2023 | 7 | |
| 5 | 2022 | 13 | |
| 6 | 2022 | 28 | |
| 7 | 2019 | 22 | |
| 8 | 2018 | 11 | |
| 9 | 2017 | 22 | |
| 10 | 2010 | 485 | |
| 11 | 2009 | 76 | |
| 12 | 2006 | 36 | |
| 13 | 2006 | 64 | |
| 14 | 2004 | 313 | |
| 15 | 2004 | 71 | |
| 16 | 2003 | 1 | |
| 17 | 2003 | 45 | |
| 18 | 2002 | 440 | |
| 19 | 1998 | 57 | |
| 20 | 1995 | 75 |
About Averil Ma
Averil Ma is a scholar working on Immunology, Cancer Research and Molecular Biology, having authored 142 papers that have together received 18.1k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (49 papers), Immune Cell Function and Interaction (36 papers), T-cell and B-cell Immunology (34 papers), Immune Response and Inflammation (32 papers), interferon and immune responses (23 papers), Immunotherapy and Immune Responses (14 papers), Ubiquitin and proteasome pathways (11 papers) and Clostridium difficile and Clostridium perfringens research (10 papers). The work is most often cited by research in Immunology (11.9k citations), Cancer Research (4.3k citations) and Oncology (2.9k citations). Averil Ma has collaborated with scholars based in United States, Japan and China. Frequent co-authors include Barbara A. Malynn, Sophia Chai, David L. Boone, Marcia Chien, James P. Lodolce, Patrick R. Burkett, Rima Koka, David L. Boone, Frederick W. Alt and Rommel Advincula. Their work appears in journals such as The Journal of Immunology, Immunity, Gastroenterology, The Journal of Experimental Medicine and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.